MASSAFFINITY
LIVE

Serial Number

79403944

Owner

MassAffinity Pty Limited

Attorney

Sarah Matthews

Filing Date

Jul 1, 2024

Add to watchlist:

No watchlists yet
View on USPTO

MASSAFFINITY Trademark

Serial Number: 79403944 • Registration: 7885592

MASSAFFINITY is a trademark filed by MassAffinity Pty Limited on July 1, 2024. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

MassAffinity Pty Limited (3 trademarks)

Unit 1021,

Entity Type: 99

Trademark Details

Filing Date

July 1, 2024

Registration Date

August 12, 2025

Published for Opposition

June 24, 2025

Goods & Services

Pharmaceutical drug development; drug discovery services, namely, development of pharmaceutical preparations and medicines; pharmaceutical research and development; drug development services; development of pharmaceuticals; development of pharmaceutical preparations and medicines; research and development of new products for the pharmaceutical industry; research and development services of new pharmaceutical products; scientific research and development; research to develop new products; conducting early evaluations in the field of new pharmaceuticals; research in the field of pharmaceuticals; research and development services for the pharmaceutical industry; biochemical research and development; laboratory research in the field of pharmaceuticals; scientific research in the field of pharmacogenomics; research and development services in the field of pharmaceutical preparations; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information about medical and scientific research in the field of pharmaceuticals; product development consultancy for inventors in the field of molecular biology; research and development in the field of biochemistry

Providing information relating to drugs, namely, providing medical information to medical professionals in the form of reports in the field of pharmaceutical interactions; drug information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; provision of information relating to drugs, namely, providing medical information to medical professionals in the form of reports in the field of pharmaceutical interactions; advisory services relating to drugs, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals

Filing History

FINAL DISPOSITION NOTICE SENT TO IB
Feb 23, 2026 FICS
FINAL DISPOSITION PROCESSED
Feb 23, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 19, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 4, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 4, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 12, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 12, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 12, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 24, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 24, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 18, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 24, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 23, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 23, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 23, 2025 TROA
REFUSAL PROCESSED BY IB
Feb 22, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 31, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jan 31, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 30, 2024 RFCR
NON-FINAL ACTION WRITTEN
Dec 29, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 27, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 9, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 9, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 5, 2024 REPR